Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)

Market Cap	2.47B
Revenue (ttm)	532.64M
Net Income (ttm)	-263.07M
Shares Out	220.00M
EPS (ttm)	-1.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,261,375
Average Volume	5,543,532
Open	11.35
Previous Close	11.35
Day's Range	11.23 - 11.58
52-Week Range	9.60 - 16.45
Beta	-0.22
RSI	43.45
Earnings Date	Nov 3, 2025

About IST:ANGEN

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cyto...

• Industry: Medical Devices
• Sector: Healthcare
• Employees: 223
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ANGEN

Financial Performance

In 2024, IST:ANGEN's revenue was 529.83 million, an increase of 54.06% compared to the previous year's 343.92 million. Losses were -218.88 million, 10.9% more than in 2023.